CYTOMEDIX INC (CMXI) has 44 open-market insider trades by 8 insiders since 2011. The most active filer is David Emerson Jorden, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David Emerson Jorden | Dir | — | 27 | $623K | 2013-05-21 |
| Richard S. Kent | Dir | — | 1 | $530K | 2013-02-22 |
| Joseph del Guercio | Dir | — | 1 | $280K | 2013-02-19 |
| B. Jefferson Clark | 10% | — | 1 | $105K | 2013-02-22 |
| Dean Tozer | Chief Commercial Officer | — | 5 | $77K | 2014-10-06 |
| Martin P. Rosendale | CEO | — | 5 | $46K | 2014-08-20 |
| Shallcross Steven a | CFO | — | 2 | $31K | 2014-08-26 |
| Andrew Scott Maslan | CFO | — | 2 | $9K | 2012-08-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Dean Tozer | Chief Commercial Officer | Buy | $12K | 2014-10-06 |
| Dean Tozer | Chief Commercial Officer | Buy | $18K | 2014-09-12 |
| Dean Tozer | Chief Commercial Officer | Buy | $14K | 2014-08-29 |
| Shallcross Steven a | CFO | Buy | $10K | 2014-08-26 |
| Dean Tozer | Chief Commercial Officer | Buy | $15K | 2014-08-22 |
| Dean Tozer | Chief Commercial Officer | Buy | $19K |
Companies that share insiders with CMXI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2014-08-20 |
| Shallcross Steven a | CFO | Buy | $20K | 2014-08-20 |
| Martin P. Rosendale | CEO | Buy | $10K | 2014-08-20 |
| David Emerson Jorden | Director | Buy | $40K | 2013-05-17 |
| David Emerson Jorden | Director | Buy | $25K | 2013-04-17 |
| David Emerson Jorden | Director | Buy | $39K | 2013-04-08 |
| Martin P. Rosendale | CEO | Buy | $9K | 2013-04-04 |
| David Emerson Jorden | Director | Buy | $13K | 2013-02-26 |
| Richard S. Kent | Director | Buy | $530K | 2013-02-22 |
| Martin P. Rosendale | CEO | Buy | $11K | 2013-02-22 |